No black box warning on record for Liposomal Hemorrhoid Master
As of the latest FDA labeling reviewed, Liposomal Hemorrhoid Master (LIDOCAINE HCL 4%, PHENYLEPHRINE HCL 0.25%) does not carry a black box warning. Standard warnings and precautions still apply — see the full Liposomal Hemorrhoid Master medicine page for the complete safety profile.